Patent Assignment
Reel/Frame 050796/0985
Change of Name
Recorded: 2019-10-22
Pages: 3
Assignor
PSIVIDA US, INC.
Executed: 2018-03-28
Assignee
EYEPOINT PHARMACEUTICALS US, INC.
480 PLEASANT STREET, SUITE B300, WATERTOWN, MASSACHUSETTS, 02472
Covered Properties
(3)
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent:
6,217,895 →
Application:
09/273,548 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Device and Method for Treating Conditions of a Joint
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 14, 2005
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 016135/0697 →
License Agreement
Oct 4, 2005
From: CONTROL DELIVERY SYSTEMS, INC.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 016851/0045 →
Security Interest
Apr 5, 2018
From: PSIVIDA CORP.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 045848/0670 →
Security Interest
Feb 13, 2019
From: EYEPOINT PHARMACEUTICALS, INC.; EYEPOINT PHARMACEUTICALS US, INC.; ICON BIOSCIENCE, INC.
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 048329/0045 →
Release of Security Interest
Feb 13, 2019
From: SWK FUNDING LLC, AS AGENT
To: PSIVIDA CORP.; PSIVIDA US, INC.; ICON BIOSCIENCE, INC.
Reel/Frame 048329/0136 →
Merger
Apr 2, 2019
From: CONTROL DELIVERY SYSTEMS, INC.; PSIVIDA INC.
To: PSIVIDA INC.
Reel/Frame 048768/0796 →
Change of Name
Apr 3, 2019
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 048787/0610 →
Release of Security Interest
Mar 14, 2022
From: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
To: EYEPOINT PHARMACEUTICALS, INC.; EYEPOINT PHARMACEUTICALS US, INC.; ICON BIOSCIENCE, INC.
Reel/Frame 059365/0112 →